Nexxt Spine has secured 510(k) clearance from the US Food and Drug Administration (FDA) and announced full commercial launch of its Saxxony posterior cervical thoracic system.
The system has been designed to stabilize cervical (C1 to C7) and thoracic (T1 to T3) spinal segments via posterior screw fixation in patients with degenerative disease, deformity, tumor, or trauma.
Nexxt Spine president Andy Elsbury said: “The SAXXONY System adds a robust posterior complement to our well received anterior cervical fixation offering as we continue to innovate and grow our fusion portfolio.
The comprehensive offering includes standard and smooth shank screws available in a variety of diameter and length combinations, low profile cross connectors featuring multi-axis adjustability, and various configurations of offset, parallel, and axial connectors. The implant offering is complemented by streamlined instrumentation designed to ease rod placement and facilitate procedural efficiency.
In order to simplify longer complex constructs, the SAXXONY Posterior Cervical Thoracic System has been designed to seamlessly link to the INERTIA Pedicle Screw System with a variety of 3.5 to 5.5mm or 3.5 to 6.5mm rod-to-rod connectors and transition rods.
Nexxt Spine is a privately held medical device manufacturer dedicated to increasing procedural efficiency and patient outcomes through development of innovative products, manufactured on the most technologically advanced platforms, and utilizing irreproachable quality standards to treat painful and debilitating spinal pathologies.
The company is growing rapidly and continues to recruit regional sales managers and independent distributors.
Source: Company Press Release